34 results
Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial

Thumbnail

D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study

Thumbnail

D2.495 - Treatment with Izicopan (INF904), an oral anti-C5aR inhibitor improves efficacy and safety in patients with chronic spontaneous urticaria: results from a Phase 2a study

Thumbnail

D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis

Thumbnail

D2.497 - Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Trial

Thumbnail

D2.498 - Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilizing Professional Care in Pediatric Patients Aged 2 to

Thumbnail

D2.499 - Immunoregulatory Effects of Dupilumab Added to Omalizumab-Facilitated Multi-Allergen Oral Immunotherapy in the COMBINE clinical trial

Thumbnail

D2.503 - LP-003 Injection for the treatment of H1 Antihistamine-Inadequately Controlled Chronic Spontaneous Urticaria (CSU): A Multicenter, Randomized, Double-Blind, Controlled Phase Ⅱ Study

Thumbnail

D2.504 - Novel food supplement containing a combination of bioactive compounds in pediatric cow’s milk protein allergy: results from a randomized, placebo-controlled trial

Thumbnail

D3.121 - Evaluation of small airway dysfunction in severe asthma treated with anti-IgE and anti-eosinophilic therapies: A prospective comparative study

Thumbnail

D3.109 - Clinical Characteristics of Asthma Patients with Fungal Sensitization: A Retrospective Cross-Sectional Study

Thumbnail

D3.110 - Patterns of Opioid or Neuromodulator Use in Chronic Cough Patients with Newly Diagnosed Asthma

Thumbnail

D3.111 - The Impact of War on the Course of Asthma

Thumbnail

D3.112 - Clinical Characteristics and Evaluation of Serum Inflammatory Markers in Patients Hospitalized Due to Asthma Exacerbations

Thumbnail

D3.113 - The Diagnostic Value of Exercise Bronchial Provocation Testing in Pediatric Asthma

Thumbnail

D3.114 - Characterization on genome-wide profile of H3K4me2 histone methylation in mouse asthmatic lung induced by Alt a 1

Thumbnail

D3.115 - Iloprost Attenuates Neutrophilic Airway Inflammation in a Murine Model of Type 2-Low Asthma

Thumbnail

D3.119 - Saving the Caregiver: Humanitarian Access to Dupilumab in a Physician with Severe Non-Allergic T2 Asthma in a Frontline Ukrainian City